Company profile for Allegro

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Allegro is a pioneering life sciences company blending biotechnology, engineering, and medical technology to develop breakthrough biomedical solutions. Founded in 2021, our mission is to enhance human health and longevity by engineering the body at the molecular level. We specialize in platform technologies for chronic degenerative diseases, focusing on musculoskeletal, connective tissue, and neuroscience advancements. Driven ...
Allegro is a pioneering life sciences company blending biotechnology, engineering, and medical technology to develop breakthrough biomedical solutions. Founded in 2021, our mission is to enhance human health and longevity by engineering the body at the molecular level. We specialize in platform technologies for chronic degenerative diseases, focusing on musculoskeletal, connective tissue, and neuroscience advancements. Driven by passion and innovation, our team is committed to pushing the boundaries of science to improve lives and advance humankind.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Belgium
Address
Address
Olieweg 95 2020 Antwerp
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/25/3194042/0/en/Allegro-and-American-Regent-sign-exclusive-licensing-deal-for-SynoglideTM-a-novel-osteoarthritis-treatment-in-animal-health-valued-at-up-to-35-million.html

GLOBENEWSWIRE
25 Nov 2025

https://www.globenewswire.com/news-release/2025/10/07/3162232/0/en/Allegro-showcases-superior-shock-absorbing-capacity-of-injectable-hydrogel-for-osteoarthritis-at-CellMech.html

GLOBENEWSWIRE
07 Oct 2025

https://www.globenewswire.com/news-release/2025/04/11/3060129/0/en/Allegro-demonstrates-safety-profile-of-osteoarthritis-hydrogel-in-data-presentation-at-World-Congress-on-Osteoporosis.html

GLOBENEWSWIRE
11 Apr 2025

https://www.globenewswire.com/news-release/2025/03/25/3048441/0/en/Allegro-s-injectable-osteoarthritis-treatment-generates-positive-safety-results-in-preclinical-studies.html

GLOBENEWSWIRE
25 Mar 2025

https://www.globenewswire.com//news-release/2025/03/04/3036183/0/en/Allegro-reports-positive-safety-data-for-its-injectable-osteoarthritis-treatment-in-three-preclinical-studies.html

GLOBENEWSWIRE
04 Mar 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty